ZACHARY BUTT: Open Payments
NPI 1114445368 · MIDDLETOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$709 in 33 payments from 14 companies in 2025. Trend: 2023 $397 · 2024 $442 · 2025 $709
Food & beverage: $709
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 9 | $124 |
| Teva Pharmaceuticals USA, Inc. | 1 | $103 |
| Novo Nordisk Inc | 3 | $83 |
| AstraZeneca Pharmaceuticals LP | 4 | $78 |
| PFIZER INC. | 3 | $57 |
| Merck Sharp & Dohme LLC | 3 | $55 |
| Dexcom, Inc. | 2 | $41 |
| Astellas Pharma US Inc | 1 | $33 |
| ABBVIE INC. | 2 | $30 |
| Globus Medical, Inc. | 1 | $28 |
Products named: VOQUEZNA, AUSTEDO XR, Ozempic, Dexcom G6 Transmitter, AIRSUPRA, ELIQUIS, Veozah, LAGEVRIO.
Industry payments across MD — which companies pay providers there.
